Adagio Medical (ADGM) analyst forecast and price target
Analyst forecast
Consensus of 3 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| LUCID CAPITAL MARKETS | Initiated Coverage | Buy | $3.00 | Jun 3, 2026 |
| Piper Sandler | Initiated Coverage | Overweight | $3.00 | Apr 14, 2026 |
| Lake Street | Initiated Coverage | Buy | $4.00 | Dec 2, 2025 |
Frequently asked questions
Is ADGM a buy, sell, or hold?
Analysts covering Adagio Medical currently average a Buy rating: 3 buy, 0 hold and 0 sell, from 3 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on ADGM?
On Jun 3, 2026, LUCID CAPITAL MARKETS initiated coverage of Adagio Medical at Buy with a price target of $3.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.